JP2025511391A5 - - Google Patents
Info
- Publication number
- JP2025511391A5 JP2025511391A5 JP2024559019A JP2024559019A JP2025511391A5 JP 2025511391 A5 JP2025511391 A5 JP 2025511391A5 JP 2024559019 A JP2024559019 A JP 2024559019A JP 2024559019 A JP2024559019 A JP 2024559019A JP 2025511391 A5 JP2025511391 A5 JP 2025511391A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- domain
- domain contains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263327288P | 2022-04-04 | 2022-04-04 | |
| US63/327,288 | 2022-04-04 | ||
| PCT/US2023/065290 WO2023196786A1 (en) | 2022-04-04 | 2023-04-03 | Anti-dectin-1 antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511391A JP2025511391A (ja) | 2025-04-15 |
| JP2025511391A5 true JP2025511391A5 (https=) | 2026-04-10 |
Family
ID=88243583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559019A Pending JP2025511391A (ja) | 2022-04-04 | 2023-04-03 | 抗デクチン－１抗体及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20250230247A1 (https=) |
| EP (1) | EP4504794A1 (https=) |
| JP (1) | JP2025511391A (https=) |
| KR (1) | KR20250006353A (https=) |
| CN (1) | CN119301156A (https=) |
| AU (1) | AU2023251034A1 (https=) |
| CA (1) | CA3255392A1 (https=) |
| IL (1) | IL315845A (https=) |
| MX (1) | MX2024012194A (https=) |
| WO (1) | WO2023196786A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| US20250223364A1 (en) * | 2022-04-04 | 2025-07-10 | Dren Bio, Inc. | Multispecific binding proteins that bind dectin-1 and cd20 and methods of use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020253621A1 (en) * | 2019-04-05 | 2021-11-11 | Dren Bio Management, Inc. | Methods of depleting disease causing agents via antibody targeted phagocytosis |
| CA3198102A1 (en) * | 2020-10-07 | 2022-04-14 | Dren Bio, Inc. | Anti-dectin-1 antibodies and methods of use thereof |
-
2023
- 2023-04-03 EP EP23785556.4A patent/EP4504794A1/en active Pending
- 2023-04-03 WO PCT/US2023/065290 patent/WO2023196786A1/en not_active Ceased
- 2023-04-03 CA CA3255392A patent/CA3255392A1/en active Pending
- 2023-04-03 JP JP2024559019A patent/JP2025511391A/ja active Pending
- 2023-04-03 IL IL315845A patent/IL315845A/en unknown
- 2023-04-03 CN CN202380043590.3A patent/CN119301156A/zh active Pending
- 2023-04-03 KR KR1020247036489A patent/KR20250006353A/ko active Pending
- 2023-04-03 US US18/850,174 patent/US20250230247A1/en active Pending
- 2023-04-03 AU AU2023251034A patent/AU2023251034A1/en active Pending
-
2024
- 2024-09-30 US US18/902,745 patent/US20250129168A1/en active Pending
- 2024-10-02 MX MX2024012194A patent/MX2024012194A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023545057A5 (https=) | ||
| JP2025511391A5 (https=) | ||
| JP7058219B2 (ja) | Ｃｄ３及びｐｓｍａに結合するヘテロ二量体抗体 | |
| US12398207B2 (en) | Heterodimeric antibodies that bind CD3 and CLDN6 | |
| ES2439802T3 (es) | Anticuerpos tri- o tetraespecíficos | |
| JP2018183173A5 (https=) | ||
| MX2011013616A (es) | Proteinas biespecificas tetravalentes de union a antigeno. | |
| US12404329B2 (en) | Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3 | |
| JP2022529154A5 (https=) | ||
| US20240279356A1 (en) | Heterodimeric antibodies that bind msln and cd3 | |
| JP2024541680A5 (https=) | ||
| AU2018387829B2 (en) | Bispecific antigen binding construct | |
| US20230151095A1 (en) | Bispecific antibodies that bind to b7h3 and nkg2d | |
| AU2023353699A1 (en) | Multispecific antibodies and methods of use thereof | |
| US20250243279A1 (en) | Bispecific antibodies that bind to nkp46 and mica/b | |
| US20240034815A1 (en) | Heterodimeric antibodies that bind cd3 and gpc3 | |
| US20240360220A1 (en) | Orthogonal multimeric proteins | |
| US20240150471A1 (en) | Natural killer cell antibodies with increased adcc activity | |
| WO2026080752A2 (en) | De novo antibodies to activin a receptor like type 1 (alk1) | |
| WO2025024780A1 (en) | Antibodies that bind gamma-delta t cell receptors for the treatment of cancer |